Marco Lizwan

Dr. Marco Lizwan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MLMarco Lizwan
Marco Lizwan
HYHao Yun Yap
Hao Yun Yap
JCJack Kian Ch’ng
Jack Kian Ch’ng
TCTze Tec Chong
Tze Tec Chong
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
Background: Endovascular therapy for lower-limb arterial disease is widely performed today. A vast array of sheaths, catheters, wires, balloon types, stents, and tools such as atherectomy, thrombectomy, and lithotripsy devices are now available to achieve the best outcomes in terms of vessel patency and ultimately limb salvage. The use of atherectomy devices, however, has raised some controversies in terms of outcome efficacy, cost effectiveness, and safety profile in various series and studies. Objectively, the types and disease pattern in these studies are also greatly heterogeneous. Methods: Here, we reported three cases which exemplify how these atherectomy devices have served as a valuable tool, especially for patients with complex and heavily calcified lesions. Results: The three cases highlighted scenarios where atherectomy displayed good outcomes, each involving the use of atherectomy devices to treat highly calcified vessels. Conclusions: Despite the concerns with atherectomy devices, we believe that with proper selection, patients will benefit most from their ability to achieve the best outcomes of both vessel patency and limb salvage.

19 August 2023 in JTCVS Techniques
Verified
Journal Article
Open access
MLMarco Lizwan
Marco Lizwan
WLWen Di Lee
Wen Di Lee
JCJia Jie Chong
Jia Jie Chong
KCKim Chai Chua
Kim Chai Chua


20 December 2025 in Patient Safety in Surgery
Verified
Journal Article
Open access
PDF file
MLMarco Lizwan
Marco Lizwan
PPPhilip Y. K. Pang
Philip Y. K. Pang
Introduction: Retained surgical items are rare yet serious complications that may occur despite correct instrument and sponge counts. Surgical sponges remain the most frequently retained items, with gauze marker strand retention being an uncommon mechanism. Case presentation: A 69-year-old male with severe mitral regurgitation and triple-vessel coronary artery disease underwent mitral valve replacement with coronary artery bypass grafting. All surgical counts were verified as correct at the conclusion of surgery. Postoperative chest radiography, however, revealed two linear radio-opaque foreign bodies near the left lower sternum. Mediastinal re-exploration identified two radio-opaque strands, measuring 3.0 cm and 2.0 cm, attached to the left lower chest wall near the internal mammary artery stump. These were confirmed to be detached marker strands from Raytec gauzes. The patient’s recovery was uneventful and he was discharged well. Conclusion: This case illustrates that retained gauze fragments can occur despite correct counts due to fragmentation of radiopaque markers. Surgeons and operating room nurses should inspect gauzes for integrity, maintain vigilance when manipulating sponges in confined operative fields, and consider adjunct technologies such as radiofrequency or barcode tracking. In high-risk surgeries, postoperative imaging may be warranted even with accurate counts to ensure patient safety.

26 March 2026 in Thoracic Cancer
Verified
Journal Article
Open access
MLMarco Lizwan
Marco Lizwan
LXLi Xiao
Li Xiao
CCChun Yuen Chow
Chun Yuen Chow
HLHiu Yeung Lau
Hiu Yeung Lau
BOBoon‐Hean Ong
Boon‐Hean Ong
GLI1 ‐altered mesenchymal tumors are exceptionally rare mesenchymal tumors, with recent molecular studies implicating GLI1 gene fusion or amplification. We report a 39‐year‐old nonsmoking woman who presented with an incidentally detected right pleural‐based mass. Cross‐sectional imaging identified a paraspinal pleural lesion at the T5–T6 level without intraspinal extension. Video‐assisted thoracoscopic resection revealed a biphasic tumor and next‐generation sequencing confirmed an ACTB‐GLI1 fusion. The diagnosis of GLI1 ‐altered mesenchymal tumor was established. After multidisciplinary discussion, the patient opted for radiologic surveillance instead of adjuvant therapy. She remains disease‐free at 1‐year follow‐up. This case expands the anatomic spectrum of GLI1 ‐altered tumors and underscores the value of molecular testing in distinguishing them from other pleural neoplasms.

28 May 2026 in JTCVS Techniques
Verified
Journal Article
Open access
SGSivaraj Pillai Govindasamy
Sivaraj Pillai Govindasamy
MLMarco Lizwan
Marco Lizwan
AMAzamal Ibrahim G. Mulla
Azamal Ibrahim G. Mulla
DHDeborah Harrington
Deborah Harrington